Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia

被引：0
|
作者：
Oliver Graupner
Anne Karge
Sarah Flechsenhar
Alina Seiler
Bernhard Haller
Javier U. Ortiz
Silvia M. Lobmaier
Roland Axt-Fliedner
Christian Enzensberger
Kathrin Abel
Bettina Kuschel
机构：
[1] University Hospital rechts der Isar,Department of Obstetrics and Gynecology
[2] Technical University of Munich,Institute for Medical Informatics, Statistics and Epidemiology (IMedIS)
[3] University Hospital rechts der Isar,Department of Obstetrics and Gynecology, Division of Prenatal Medicine, University Hospital UKGM
[4] Technical University of Munich,undefined
[5] Justus-Liebig University,undefined
来源：
Archives of Gynecology and Obstetrics | 2020年 / 301卷
关键词：
Preeclampsia; (anti-) Angiogenic factors; Placental growth factor; Soluble fms-like tyrosine kinase 1; Cerebroplacental ratio; Uterine artery Doppler;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：375 / 385
页数：10
相关论文
共 50 条
  • [41] Evaluation of the utility of the sFlt-1/PlGF ratio in pregnancy complicated by pre-eclampsia - single-center study. Preliminary analysis
    Kuciel, Justyna A.
    Sarad, Jagoda N.
    Mroczek, Natalia M.
    Jaworowski, Andrzej
    Kolak, Magdalena L.
    Huras, Hubert K.
    GINEKOLOGIA POLSKA, 2025, 96 (02) : 148 - 152
  • [42] Re: Perinatal outcome and placental apoptosis in patients with late-onset pre-eclampsia and abnormal uterine artery Doppler at diagnosis diagnosis.
    Leslie, K.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2018, 51 (06) : 719 - 719
  • [43] Evaluation of sFlt-1/PlGF Ratio for predicting and Improving clinical management of pre-eclampsia in lupus nephritis: a single case experience in CHUV
    Ventresca, Mariangela
    Spertini, Francois
    Desseauve, David
    Legardeur, Helene
    Kissling, Sebastien
    Beaud, Floriane
    Schwotzer, Nora
    Rotman, Samuel
    Tsai Chun-yi
    Gregoire, Wuerzner
    Phan, Olivier
    SWISS MEDICAL WEEKLY, 2018, 148 : 28S - 28S
  • [44] Literature Review: The sFlt1/PlGF Ratio and Pregestational Maternal Comorbidities: New Risk Factors to Predict Pre-Eclampsia
    Karpova, Nataliia Sergeevna
    Dmitrenko, Olga Pavlovna
    Budykina, Tatyana Sergeevna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [45] Performance of sFlt-1/PIGF Ratio for the Prediction of Perinatal Outcome in Obese Pre-Eclamptic Women
    Karge, Anne
    Desing, Linus
    Haller, Bernhard
    Ortiz, Javier U.
    Lobmaier, Silvia M.
    Kuschel, Bettina
    Graupner, Oliver
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [46] Early versus late-onset fetal growth restriction (FGR): Analysis of soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (plgf) levels and sFlt-1/PLGF Ratio
    Bednarek-Jedrzejek, M.
    Ksel-Hryciow, J.
    Tousty, P.
    Kwiatkowska, E.
    Cymbaluk-Ploska, A.
    Torbe, A.
    Kwiatkowski, S.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 270 : E59 - E59
  • [47] Re: Screening for pre-eclampsia using sFlt-1/PlGF ratio cut-off of 38 at 30-37 weeks' gestation
    Vatish, M.
    Stepan, H.
    Hund, M.
    Verlohren, S.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2017, 49 (05) : 665 - +
  • [48] Role of sFLT-1/PlGF ratio in predicting severe adverse materno-fetal outcome in high risk women
    Kumar, Manisha
    Balyan, Kirti
    Debnath, Ekta
    Shankar, Shivangi
    Apte, Aryahi
    Jha, Shreeja
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2022, 30 : 154 - 160
  • [49] THE PRERATIO STUDY: IS THE SFLT-1/PLGF RATIO A SUITABLE MARKER TO DIAGNOSE PREECLAMPSIA AND TO PREDICT ADVERSE MATERNAL/NEONATAL PREGNANCY OUTCOME?
    Saleh, L.
    Verdonk, K.
    Danser, A. H. J.
    Steegers, E. A. P.
    Russcher, H.
    Van den Meiracker, A. H.
    Visser, W.
    JOURNAL OF HYPERTENSION, 2015, 33 : E347 - E348
  • [50] Medical input of blood ratio sflt-1/PLGF for pre-eclampsia diagnosis: Analytical study in the university Hospital Croix-Rousse in Lyon
    Galofaro, E.
    Lacaille, L.
    Huissoud, C.
    Poggi, B.
    CLINICA CHIMICA ACTA, 2019, 493 : S600 - S601
12345